ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.518,03
-0,44%
S&P 500
5.646,98
0,28%
Dow Jones
40.852,61
1,59%
Euro vs US Dollar
1,08918
-0,07%
Bitcoin
64.601,49
-0,39%
Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Angiotech Pharmaceuticals - Common Shares (MM) (ANPI)

  7. Angiotech Pharmaceuticals - Common Shares (MM) (ANPI) News

ANPI

Angiotech Pharmaceuticals - Common Shares (MM) (ANPI)

Angiotech Pharmaceuticals - Common Shares (MM)
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:ANPI
DatumZeitQuelleÜberschriftSymbolFirma
16/03/201013h30PR Newswire (US)Study shows superior efficacy for TAXUS(R) Express(R) Stents at one year compared to bare-metal stents in diabetic patients expeNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
15/03/201019h00PR Newswire (US)Angiotech Pharmaceuticals announces PERSEUS trial results demonstrate positive safety and efficacy outcomes for Boston ScientifiNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
10/03/201002h56Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
10/03/201002h46Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
10/03/201002h26Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
10/03/201001h55Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
10/03/201001h41Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
10/03/201000h33Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
09/03/201021h24Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
09/03/201021h08Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
09/03/201021h01Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
09/03/201020h52Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
05/03/201022h50Edgar (US Regulatory)Statement of Ownership (SC 13G)NASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
17/02/201015h00PR Newswire (US)Angiotech Pharmaceuticals and partner Athersys announces completion of patient enrollment in phase I study of Multistem(R) in acNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
17/02/201015h00PR Newswire (US)Angiotech Pharmaceuticals and partner Athersys announces completion of patient enrollment in phase I study of Multistem(R) in acNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
17/02/201015h00PR Newswire (US)Angiotech Pharmaceuticals and partner Athersys announces completion of patient enrollment in phase I study of Multistem(R) in acNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
17/02/201015h00PR Newswire (US)Angiotech Pharmaceuticals and partner Athersys announces completion of patient enrollment in phase I study of Multistem(R) in acNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
17/02/201015h00PR Newswire (US)Angiotech Pharmaceuticals and partner Athersys announces completion of patient enrollment in phase I study of Multistem(R) in acNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
17/02/201015h00PR Newswire (US)Angiotech Pharmaceuticals and partner Athersys announces completion of patient enrollment in phase I study of Multistem(R) in acNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
17/02/201015h00PR Newswire (US)Angiotech Pharmaceuticals and partner Athersys announces completion of patient enrollment in phase I study of Multistem(R) in acNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
17/02/201015h00PR Newswire (US)Angiotech Pharmaceuticals and partner Athersys announces completion of patient enrollment in phase I study of Multistem(R) in acNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
17/02/201015h00PR Newswire (US)Angiotech Pharmaceuticals and partner Athersys announces completion of patient enrollment in phase I study of Multistem(R) in acNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
17/02/201015h00PR Newswire (US)Angiotech Pharmaceuticals and partner Athersys announces completion of patient enrollment in phase I study of Multistem(R) in acNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
17/02/201015h00PR Newswire (US)Angiotech Pharmaceuticals and partner Athersys announces completion of patient enrollment in phase I study of Multistem(R) in acNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
17/02/201015h00PR Newswire (US)Angiotech Pharmaceuticals and partner Athersys announces completion of patient enrollment in phase I study of Multistem(R) in acNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
17/02/201015h00PR Newswire (US)Angiotech Pharmaceuticals and partner Athersys announces completion of patient enrollment in phase I study of Multistem(R) in acNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
17/02/201015h00PR Newswire (US)Angiotech Pharmaceuticals and partner Athersys announces completion of patient enrollment in phase I study of Multistem(R) in acNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
17/02/201015h00PR Newswire (US)Angiotech Pharmaceuticals and partner Athersys announces completion of patient enrollment in phase I study of Multistem(R) in acNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
17/02/201015h00PR Newswire (US)Angiotech Pharmaceuticals and partner Athersys announces completion of patient enrollment in phase I study of Multistem(R) in acNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
17/02/201015h00PR Newswire (US)Angiotech Pharmaceuticals and partner Athersys announces completion of patient enrollment in phase I study of Multistem(R) in acNASDAQ:ANPIAngiotech Pharmaceuticals - Common Shares (MM)
 Showing the most relevant articles for your search:NASDAQ:ANPI

Kürzlich von Ihnen besucht

LSE
AFMC
Aberdeen Frontier Market...
LSE
LOAD
Crestchic
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten